Clinical trial
A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Four-Arm Trial to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo for the Treatment of Abdominal Pain in Patients With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
NCT01076699 is registered in ClinicalTrials.gov with Revogenex, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Four-Arm Trial to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo for the Treatment of Abdominal Pain in Patients With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
- Lead sponsor
- Revogenex, Inc.
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- March 31, 2010
- Completion date
- March 31, 2011
- Enrollment
- 192 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.